Tesla
TSLA
Apple
AAPL
Meta Platforms
META
Microsoft
MSFT
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
STOK Stoke Therapeutics
- 8.150
- -0.180-2.16%
Close Mar 21 16:00 ET
- 8.150
- 0.0000.00%
Post 20:01 ET
440.73MMarket Cap-4.94P/E (TTM)
8.350High7.660Low1.41MVolume8.210Open8.330Pre Close11.28MTurnover3.79%Turnover RatioLossP/E (Static)54.08MShares17.58052wk High1.92P/B302.60MFloat Cap6.29052wk Low--Dividend TTM37.13MShs Float71.580Historical High--Div YieldTTM8.28%Amplitude3.350Historical Low8.016Avg Price1Lot Size
About Stoke Therapeutics Company
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
Company Profile
SymbolSTOK
Company NameStoke Therapeutics
Listing DateJun 19, 2019
Issue Price18.00
Founded2014
CEOMr. Ian F. Smith
MarketNASDAQ
Employees128
Fiscal Year Ends12-31
Address45 Wiggins Avenue
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-781-430-8200
Company Executives
- Name
- Position
- Salary
- Ian F. Smith
- Interim Chief Executive Officer and Director
- 394.03K
- Barry S. Ticho, M.D.,PhD
- Chief Medical Officer
- 1.65M
- Thomas E. Leggett
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Huw M. Nash, PhD
- Chief Business Officer
- --
- Dr. Arthur O. Tzianabos, PhD
- Interim Executive Chairman of the Board
- 211.83K
- Dr. Edward M. Kaye, M.D.
- Director
- 3.53M
- Dr. Seth L. Harrison, M.D.
- Independent Director
- 237.33K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 199.33K
- Julie Anne Smith
- Independent Director
- 206.83K
- Professor Adrian R. Krainer, PhD
- Independent Director
- 198.33K
- Dr. Arthur A. Levin,PhD
- Independent Director
- 198.33K
- Jennifer C. Burstein, C.P.A.
- Independent Director
- 209.33K
- Jonathan Allan
- General Counsel and Corporate Secretary
- --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.